These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19110206)

  • 1. Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease.
    Bolognesi ML; Cavalli A; Melchiorre C
    Neurotherapeutics; 2009 Jan; 6(1):152-62. PubMed ID: 19110206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond.
    Bolognesi ML; Rosini M; Andrisano V; Bartolini M; Minarini A; Tumiatti V; Melchiorre C
    Curr Pharm Des; 2009; 15(6):601-13. PubMed ID: 19199985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitarget-directed ligands: innovative chemical probes and therapeutic tools against Alzheimer's disease.
    Bolognesi ML; Simoni E; Rosini M; Minarini A; Tumiatti V; Melchiorre C
    Curr Top Med Chem; 2011 Nov; 11(22):2797-806. PubMed ID: 22039879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Pan W; Hu K; Bai P; Yu L; Ma Q; Li T; Zhang X; Chen C; Peng K; Liu W; Sang Z
    Bioorg Med Chem Lett; 2016 May; 26(10):2539-2543. PubMed ID: 27072909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity.
    Bolognesi ML; Bartolini M; Tarozzi A; Morroni F; Lizzi F; Milelli A; Minarini A; Rosini M; Hrelia P; Andrisano V; Melchiorre C
    Bioorg Med Chem Lett; 2011 May; 21(9):2655-8. PubMed ID: 21236667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks.
    Bolognesi ML; Cavalli A; Bergamini C; Fato R; Lenaz G; Rosini M; Bartolini M; Andrisano V; Melchiorre C
    J Med Chem; 2009 Dec; 52(23):7883-6. PubMed ID: 19813747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of monomeric derivatives to probe memoquin's bivalent interactions.
    Bolognesi ML; Chiriano G; Bartolini M; Mancini F; Bottegoni G; Maestri V; Czvitkovich S; Windisch M; Cavalli A; Minarini A; Rosini M; Tumiatti V; Andrisano V; Melchiorre C
    J Med Chem; 2011 Dec; 54(24):8299-304. PubMed ID: 22054058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease.
    Capurro V; Busquet P; Lopes JP; Bertorelli R; Tarozzo G; Bolognesi ML; Piomelli D; Reggiani A; Cavalli A
    PLoS One; 2013; 8(2):e56870. PubMed ID: 23441223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward the discovery and development of efficacious BACE inhibitors.
    Durham TB; Shepherd TA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):776-91. PubMed ID: 17117686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics.
    Mouchlis VD; Melagraki G; Zacharia LC; Afantitis A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the photostability properties of memoquin, a quinone derivative for the treatment of Alzheimer's disease.
    Mancini F; Bolognesi ML; Melchiorre C; Andrisano V
    J Pharm Biomed Anal; 2009 Sep; 50(2):164-70. PubMed ID: 19464839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the development of anti-amyloid drugs for treatment of Alzheimer's disease.].
    Shitaka Y; Mitani Y; Nagakura A; Miyake A; Matsuoka N
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):15-20. PubMed ID: 20628208
    [No Abstract]   [Full Text] [Related]  

  • 13. Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment.
    Gazova Z; Soukup O; Sepsova V; Siposova K; Drtinova L; Jost P; Spilovska K; Korabecny J; Nepovimova E; Fedunova D; Horak M; Kaniakova M; Wang ZJ; Hamouda AK; Kuca K
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):607-619. PubMed ID: 27865910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
    Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
    Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to special issue on Alzheimer's disease.
    Wolfe MS
    J Med Chem; 2012 Nov; 55(21):8977-8. PubMed ID: 23039833
    [No Abstract]   [Full Text] [Related]  

  • 16. A small molecule targeting the multifactorial nature of Alzheimer's disease.
    Cavalli A; Bolognesi ML; Capsoni S; Andrisano V; Bartolini M; Margotti E; Cattaneo A; Recanatini M; Melchiorre C
    Angew Chem Int Ed Engl; 2007; 46(20):3689-92. PubMed ID: 17397121
    [No Abstract]   [Full Text] [Related]  

  • 17. Current therapeutic targets for the treatment of Alzheimer's disease.
    Grill JD; Cummings JL
    Expert Rev Neurother; 2010 May; 10(5):711-28. PubMed ID: 20420492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character.
    Clarke B; Demont E; Dingwall C; Dunsdon R; Faller A; Hawkins J; Hussain I; MacPherson D; Maile G; Matico R; Milner P; Mosley J; Naylor A; O'Brien A; Redshaw S; Riddell D; Rowland P; Soleil V; Smith KJ; Stanway S; Stemp G; Sweitzer S; Theobald P; Vesey D; Walter DS; Ward J; Wayne G
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1017-21. PubMed ID: 18166458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: Mental plaque removal.
    De Strooper B; Woodgett J
    Nature; 2003 May; 423(6938):392-3. PubMed ID: 12761533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.